Texas Roundup: Filament Labs, LiveOak, Capital Royalty, Alafair
Here is the latest innovation news from Texas:
—Austin, TX-based Filament Labs announced Thursday that it has raised $1 million in seed funding to develop an app that creates digital patient self-care programs with task reminders and educational information and videos. The round was led by Mercury Fund in Houston.
—LiveOak Venture Partners closed Tuesday on its inaugural $109 million venture fund aimed at early-stage technology companies. The Austin-based firm began raising money in December and has so far invested in CS Disco, a Houston-based legal IT firm; StepOne, an Austin startup that has developed customer service software; and Veros Systems, which has predictive analytics software.
—Capital Royalty in Houston also announced Tuesday that it and New Zealand-based Milford Active Growth Fund have collectively invested $14 million into AFT Pharmaceuticals, which is also based in New Zealand. Capital Royalty will also provide additional capital of up to $30 million in a structured loan facility to the 17-year-old drug company.
—Alafair Biosciences last week received a $2 million grant from the Texas Emerging Technology Fund to further the development of the firm’s internal wound-healing devices. Alafair, which is based in Austin, licensed the technology from the University of Texas at Austin.